BIOMAT Database Logo BIOMAT Database Logo

[Complications of the holmium laser enucleation of prostate for benign prostatic hyperplasia]. 2018

D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Research Institute for Uronephrology and Human Reproductive Health, Department of Urology, R.M. Fronshteyn Urology Clinic, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.

BACKGROUND With growing experience in the HoLEP, it can replace TURP as the "gold standard" for the surgical management of BPH, and therefore this technique is the most studied surgical modality. Despite the proven effectiveness of HoLEP in the treatment of patients with BPH, its widespread use has been associated with both intra- and postoperative complications. OBJECTIVE To improve the results of surgical management of patients with BPH. METHODS The study comprised 310 patients who underwent HoLEP for BPH. HoLEP was performed using the Gillings technique. METHODS presence of LUTS (Qmax<15 ml/s, Qav<10 ml/s, presence of residual urine, I-PSS score> 5, QoL score> 2), absence of an active inflammatory process of the urogenital organs. RESULTS Intraoperative complications included severe hemorrhage in 16 (5.2%), the bladder wall injury in 17 (5.5%) and the ureteral orifice injury in 2 (0.6%) patients. 275 (88.7%) had no intraoperative complications. Early postoperative complications included fever in 4 (1.3%), the bladder tamponade that required cystoscopy and evacuation of blood clots in 7 (2.3%) and acute urinary retention in 36 (11.8%) patients. 263 (84.6%) patients had no postoperative complications. Long-term postoperative complications comprised urinary incontinence in 39 (12.6%) patients and urethral strictures requiring surgical treatment in 9 (2.9%) patients. There were no long-term complications in 262 (84.5%) patients. CONCLUSIONS HoLEP is an effective and safe surgical modality for treating patients with BPH with minimal complications, suitable for any size of the prostate.

UI MeSH Term Description Entries
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Holmium laser enucleation of the prostate technique for benign prostatic hyperplasia.
February 2012, The Canadian journal of urology,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
[Plasmakinetic enucleation of the prostate versus holmium laser enucleation of the prostate for benign prostatic hyperplasia].
December 2018, Zhonghua nan ke xue = National journal of andrology,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia.
September 2013, Korean journal of urology,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
March 2018, Journal of visualized experiments : JoVE,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
[Benign prostatic hyperplasia -- transurethral holmium-laser enucleation even in large prostate].
July 2006, Aktuelle Urologie,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
[Transurethral holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia].
September 2006, Zhonghua yi xue za zhi,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Salvage Holmium laser enucleation of prostate to treat residual benign prostatic hyperplasia.
March 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
[A meta-analysis of holmium laser enucleation of the prostate for benign prostatic hyperplasia].
December 2011, Zhonghua nan ke xue = National journal of andrology,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Holmium laser enucleation of the prostate for very large benign prostatic hyperplasia (≥ 200 cc).
January 2021, World journal of urology,
D S Davydov, and D G Tsarichenko, and E A Bezrukov, and R B Sukhanov, and A Z Vinarov, and N I Sorokin, and D V Enikeev, and A M Dymov, and S P Danilov
Postoperative infectious complications in our early experience with holmium laser enucleation of the prostate for benign prostatic hyperplasia.
March 2013, Korean journal of urology,
Copied contents to your clipboard!